Recombinant Factor VIIa for Refractory Bleeding Following Orthotopic Heart Transplantation

Jeremy D. Flynn, Mehrnaz Pajoumand, Phillip C. Camp, M. Salik Jahania, Chand Ramaiah, Wendell S. Akers

Annals of Pharmacotherapy · 2004 · 23 citations · 8 references

Abstract

rFVIIa appears to be a viable option as rescue therapy for treatment of refractory bleeding following orthotopic heart transplantation. Despite the anecdotal success of rFVIIa in this setting, further clinical research is needed.

References

8